![[Translate to Englisch:] Fraunhofer Logo](/fileadmin/user_upload/Science_Campus/Fraunhofer.png "[Translate to Englisch:]")
The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of 76 institutes of the Fraunhofer-Gesellschaft, the largest organization for applied research in Europe. Headquartered in Hannover, Fraunhofer ITEM focuses on respiratory research – the R&D portfolio covers three business units: drug development, chemical safety, and translational biomedical engineering. At the Science Campus Braunschweig-Süd, a multidisciplinary team is developing biopharmaceutical manufacturing processes up to GMP-compliant manufacturing of active ingredients and investigational medicinal products for clinical trials.
https://www.item.fraunhofer.de/en/r-d-expertise/rna-technologies/project-rnauto.html
© Photos: Fraunhofer ITEM, Ralf Mohr
FOUNDED IN
1981 in Hannover
SITES OF FRAUNHOFER ITEM
Hannover (headquarter), Braunschweig, Regensburg
EXECUTIVE DIRECTOR
Prof. Dr. Norbert Krug
HEAD OF PHARMACEUTICAL BIOTECHNOLOGY
Dr. Holger Ziehr
The Division of Pharmaceutical Biotechnology has been part of Fraunhofer ITEM since 2008
EMPLOYEES
about 480
EMPLOYEES IN THE DIVISION OF PHARMACEUTICAL BIOTECHNOLOGY
60
AT THE BRAUNSCHWEIG SITE
S1 and S2 laboratories, Class B, C, and D clean rooms
Contact
Dr. Cathrin Nastevska, Press and Public Relations
Phone +49 511 5350-225
E-Mail cathrin.nastevska@item.fraunhofer.de
Fraunhofer ITEM Nikolai-Fuchs-Str. 1 30625 Hannover
